Practice question

Answer the question and get instant feedback.

MediumPharmacology & PrescribingSchizophreniaukmlamrcgp aktmrcp part 1prescribing safety assessment

A patient with schizophrenia on olanzapine develops significant weight gain and metabolic syndrome. According to NICE, which antipsychotic has a lower metabolic risk and may be considered?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.